| API | Active pharmaceutical ingredient |
| AUC | Area under the curve |
| Cmax | Maximum concentration |
| CQA | Critical quality attribute |
| CQAs | Critical quality attributes |
| CsA | Cyclosporine A |
| DED | Dry eye disease |
| DLP | Digital light processing |
| FDA | Food and Drug Administration |
| FT-IR | Fourier-transform infrared spectroscopy |
| FTN | Fluorescent tracing nanoparticles |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HAMA | Methacrylate-modified hyaluronic acid |
| HBC | Hydroxybutyl chitosan |
| HPLC | High-performance liquid chromatography |
| ICH | International Council for Harmonisation |
| IOP | Intraocular pressure |
| IVIS | In vivo imaging system |
| LAP | Lithium phenyl-2,4,6-trimethylbenzoylphosphinate |
| L-PPDS | Latanoprost punctal plug delivery system |
| N-PPDS | Nepafenac punctal plug delivery system |
| NMP | N-methyl-2-pyrrolidone |
| PEG | Polyethylene glycol |
| PEG 400 | Polyethylene glycol 400 |
| PEGDA | Polyethylene glycol diacrylate |
| PPDS | Punctal plug delivery system |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PVP | Polyvinylpyrrolidone |
| QbD | Quality by design |
| QTPP | Target product quality profile |
| SEM | Scanning electron microscopy |
| SFMA | Silk fibroin methacrylate |
| TEM | Transmission electron microscopy |
| UV | Ultraviolet |